Influence of Lipid Lowering on Impaired Coronary Flow
Condition: Coronary Artery Disease Intervention: Drug: atorvastatin, rosuvastatin, ezetimibe Sponsors: Aarhus University Hospital; HeartFlow, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 10, 2022 Category: Research Source Type: clinical trials
Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
Conditions: Dyslipidemias; Atherosclerosis; Diabetes Mellitus, Type 2 Interventions: Drug: Omega 3-Atorvastatin; Drug: Atorvastatin-Ezetimibe Sponsors: Seoul National University Bundang Hospital; Korea United Pharm. Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2022 Category: Research Source Type: clinical trials